EDGEWISE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.05 USD | +5.44% |
|
+13.06% | +55.85% |
| 04-23 | Edgewise Therapeutics Secures Orphan Drug Designations for Sevasemten in EU | MT |
| 04-22 | RBC Raises Price Target on Edgewise Therapeutics to $32 From $28, Keeps Outperform, Speculative Risk | MT |
Chart calendar Edgewise Therapeutics, Inc.
705b245ec7d0e1.DfAQMLqMGUwhjOeixCsN7YUUUp8YwFicsDmZD3ttHwA.fKdqYc7DLxlr7YnylhM1i7F3AO53gh7p-kP0VyM1VEJ3u2YA0eMqfG301w~f74ec7f1b8c40f4ded98c0bc0bb9132e
Upcoming events on Edgewise Therapeutics, Inc.
Past events on Edgewise Therapeutics, Inc.
| 16/04/2024 18:12 | American Academy of Neurology Meeting |
| 16/04/2024 13:30 | ARCH EDG-5506 Two Year Topline Study Results |
| 02/04/2024 19:20 | Cantor Fitzgerald Muscular Dystrophy Symposium |
| 11/03/2024 16:00 | Leerink Partners Global Biopharma Conference |
| 06/03/2024 16:15 | Muscular Dystrophy Association Clinical & Scientific Conference |
| 03/03/2024 | Muscular Dystrophy Association Clinical & Scientific Conference - Poster Number: M146 |
| 03/03/2024 | Muscular Dystrophy Association Clinical & Scientific Conference - Poster Number: M147 |
| 03/03/2024 | Muscular Dystrophy Association Clinical & Scientific Conference - Poster Number: M145 |
| 22/02/2024 13:00 | Q4 2023 Earnings Release |
| 09/01/2024 18:30 | JPMorgan Healthcare Conference |
| 29/11/2023 13:00 | Piper Sandler Healthcare Conference |
| 15/11/2023 15:55 | Stifel Healthcare Conference |
| 13/11/2023 19:20 | American Heart Association Scientific Meeting |
| 11/11/2023 16:30 | American Heart Association Scientific Meeting |
| 09/11/2023 13:00 | Q3 2023 Earnings Release |
| 06/10/2023 19:00 | World Muscle Society International Congress - Effects of EDG-5506 |
| 06/10/2023 19:00 | World Muscle Society International Congress - Development of a conceptual |
| 06/10/2023 19:00 | World Muscle Society International Congress - Characterization |
| 03/10/2023 21:30 | Investor Meeting - Key Opinion Leaders |
| 10/08/2023 13:00 | Q2 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -42,9 -41,7 -2.86% | -71,3 -69,7 -2.29% | -113 -109 -3.28% | -130 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -43,2 -42,0 -2.9% | -71,7 -70,4 -1.78% | -114 -111 -3.05% | -141 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -42,8 -43,0 0.51% | -67,6 -69,8 3.15% | -100 -97,2 -3.08% | -126 |
|
Net income Million USD | Released Forecast Spread | -17,1 | -42,8 -43,9 2.39% | -67,6 -69,3 2.43% | -100 -98,3 -1.94% | -131 |
|
EPS USD | Released Forecast Spread | -0,12 | -1,14 -1,17 2.8% | -1,26 -1,32 4.59% | -1,57 -1,55 -1.46% | -1,76 |
| Announcement Date | 05/03/21 | 24/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -12,7 -12,9 0.82% | -14,7 -14,0 -5.62% | -16,4 -16,8 2.6% | -18,2 -18,9 4.15% | -22,0 -21,7 -1.35% | -25,5 -23,6 -8.23% | -25,6 | -29,0 -26,4 -9.85% | -33,4 -29,5 -13.09% | -29,3 | -30,5 | -33,9 | -36,4 | |
|
EBIT Million USD | Released Forecast Spread | -12,8 -11,6 -10.51% | -14,8 -13,8 -7.06% | -16,5 -16,3 -1.22% | -18,3 -18,4 0.87% | -22,1 -20,9 -5.73% | -25,7 -22,7 -13.37% | -25,3 -26,4 4.18% | -29,5 -26,9 -9.34% | -33,9 -30,7 -10.34% | -33,6 | -34,7 | -36,6 | -39,0 | -35,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -12,7 -13,0 2.15% | -14,7 -13,8 -6.19% | -16,1 -16,9 4.65% | -17,5 -19,0 7.78% | -19,4 -21,7 10.63% | -22,8 -23,6 3.33% | -21,5 -24,5 12.37% | -25,7 -24,5 -4.95% | -30,1 -27,2 -10.96% | -30,1 | -31,0 | -33,3 | -35,1 | -35,6 |
|
Net income Million USD | Released Forecast Spread | -12,7 -13,8 7.67% | -14,7 -13,9 -5.44% | -16,1 -16,7 3.79% | -17,5 -18,7 6.34% | -19,4 -21,2 8.35% | -22,8 -23,4 2.47% | -21,5 -25,5 15.73% | -25,7 -25,9 0.82% | -30,1 -28,3 -6.61% | -31,4 | -32,5 | -34,7 | -36,5 | -35,6 |
|
EPS USD | Released Forecast Spread | -0,26 -0,28 6.54% | -0,30 -0,28 -6.19% | -0,32 -0,34 4.95% | -0,34 -0,36 5.15% | -0,31 -0,36 13.24% | -0,36 -0,37 1.94% | -0,34 -0,41 16.42% | -0,41 -0,41 -0.37% | -0,47 -0,44 -5.98% | -0,40 | -0,40 | -0,42 | -0,43 | -0,51 |
| Announcement Date | 24/02/22 | 11/05/22 | 04/08/22 | 03/11/22 | 23/02/23 | 11/05/23 | 10/08/23 | 09/11/23 | 22/02/24 | - | - | - | - | - |
More events
Past sector events for Edgewise Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EWTX Stock
- Calendar Edgewise Therapeutics, Inc.
